ArticleCell death & disease2025
Hypoxic tumor exosomes suppress macrophage inflammation and ferroptosis via NDUFV2 to enhance bystander tumor radioresistance.
Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Exosome-loaded nanoradiosensitizers in radiotherapy for preventing post-irradiation tumor recurrence: mechanisms, preclinical evidence, and translational challenges.Discover nano · 2026Review
- Review
- Extracellular Vesicles Associated Metabolites as Intercellular Signalling Mediators in Disease and Therapy.Metabolites · 2026Review
- Bidirectional regulation between ferroptosis and tumor-associated macrophages: mechanisms, strategies, and therapeutic perspectives.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Hypoxia-induced radioresistance presents a major barrier to effective radiotherapy of non-small cell lung cancer (NSCLC), while the underlying role of macrophages remaining elusive. In this study, we found that, compared with normoxia-derived tumor exosomes, hypoxia-derived tumor exosomes more potently promoted M2 polarization of macrophages and TGF-β1/IL-10 secretion via NADH: ubiquinone oxidoreductase core subunit V2 (NDUFV2), as evidenced by the increased mitochondrial functions, including oxidative phosphorylation, ATP levels and mitochondrial membrane potentials, which collectively suppressed macrophage ferroptosis in an NDUFV2-dependent manner. When co-cultured with these exosome-educated macrophages, bystander normoxic NSCLC cells acquired radioresistance, which was attributed to the inhibition of ferroptosis. Notably, NDUFV2-knockdown macrophages abrogated this exosome-induced radioresistance. Mechanistically, IL-10 might be a pivotal signaling messenger rendering radioresistance of bystander normoxic cells. In vivo, hypoxic exosomes also conferred radioresistance to NSCLC xenografts in mice with intact macrophage populations but not in those with macrophage depletion. Immunohistochemical analysis revealed that irradiated xenografts treated with hypoxic exosomes exhibited significantly higher expression levels of GPX4, Ki67, HIF1α, CD163, and NDUFV2. Furthermore, GPX4 knockdown in xenografts reversed the radioresistance induced by hypoxic exosomes and was associated with reduced infiltration of M2-polarized macrophages, supporting the central role of ferroptosis in macrophage-regulated, hypoxia-induced radioresistance. Clinical tissue microarray analysis further confirmed that NDUFV2 was significantly upregulated in NSCLC tissues and correlated with advanced stages. Collectively, this study disclosed for the first time that hypoxic exosomes suppressed macrophage inflammatory responses and ferroptosis via NDUFV2, thereby enhancing radioresistance in bystander normoxic NSCLC cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.